Firefly Neuroscience, an AI-driven company focusing on brain health, has officially announced the appointment of healthcare industry leader David Johnson as its Executive Chairman upon the successful closing of its merger with WaveDancer, Inc. Johnson, with a storied career including roles as CEO of Enveric Biosciences and President of the ConvaTec Division at Bristol-Myers Squibb, is expected to bring invaluable expertise and leadership to Firefly as it embarks on a new phase of growth. This strategic move comes in the wake of an approved definitive merger agreement that has garnered support from shareholders of both companies. Jon Olsen, CEO of Firefly, has emphasized the company’s commitment to strengthening its executive team with highly skilled professionals to advance its innovative mental health solutions.

Healthcare Technology, Mergers and Acquisitions, Information Technology Services,Fairfax, VA, Toronto, Canada